Memory Health Awarded UK Patent as Alzheimer’s Treatment

Memory Health Awarded UK Patent as Alzheimer’s Treatment
The United Kingdom has awarded Memory Health a patent for a proprietary brain health supplement developed to prevent and treat neurodegenerative disease. Also called Memory Health, the all-natural nutritional supplement is made especially for Alzheimer’s disease (AD) and dementia patients. The company is the sole licensee for the formulation patented by the United Kingdom Patent Office. “This is a major milestone in the endless quest to prevent and treat neurodegenerative diseases like dementia and Alzheimer’s disease,” said Frederic J. Jouhet, founder of Michigan-based Memory Health, in a press release. “We’re so happy to be able to provide hope for current sufferers and their families, as well as a solution to prevent future disease, using a scientifically designed and scientifically tested nutritional supplement,” he said. Developed by European investigators who for decades studied the role of nutrition in brain health, the Memory Health formula was ultimately tested in three clinical trials on patients with healthy brains and on those with AD. Published in the April 2018 issue of the Journal of Alzheimer’s Disease , trial results showed improvement in memory and brain health for all who used the formula. Caregivers also reported that AD patients taking Memory Health experienced enhanced memory, vision and overall quality of life. “The inventors have found that the macular carotenoids such as a mixture of meso-zeaxanthin, lutein and zeaxanthin, or omega-3 fatty acids, given separately, have no effect individually on the progression of dementia, but when given together are remarkably and surprisingly effective in halting or retarding the progression of the disease, and improving cognitive function,” according to the patent summary.
Subscribe or to access all post and page content.